{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-007258","form_type":"8-K","ticker":"DDD","cik":"0000910638","company_name":"3D SYSTEMS CORP","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.972130+00:00","generated_at":"2026-06-22T02:31:45.537447+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"3D Systems Q3 revenue $132.3M, net loss $37.4M; narrows FY22 guidance","bullets":["Revenue $132.3M, down 15.3% YoY; non-GAAP ex-divestitures and constant currency up 2.7%.","Net loss $(37.4)M, diluted EPS $(0.30); adjusted EPS $(0.05); Adjusted EBITDA $(0.3)M vs $11.6M.","Industrial revenue $68.1M (non-GAAP ex-div. +9.0% CC); Healthcare $64.2M (non-GAAP ex-div. -3.5% CC).","Cash & short-term investments $609.4M; YTD cash used in ops $52.4M, $84.7M for acquisitions.","FY22 revenue guidance narrowed to $535-545M; non-GAAP operating expenses improved to $240-245M."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-007258","json":"https://secwatch.observer/filing/0001171843-22-007258.json","markdown":"https://secwatch.observer/filing/0001171843-22-007258.md","text":"https://secwatch.observer/filing/0001171843-22-007258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910638/000117184322007258/0001171843-22-007258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910638/000117184322007258/f8k_110822.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T02:31:45.537447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09885bc7c5cea453e47a4c2f51ce92ea9d82f744","claim":"3D SYSTEMS CORP reported the third quarter ended September 30, 2022 results: revenue $132.3 million, net income $(37.4) million, EPS $(0.30).","evidence_excerpt":"Revenue of $132.3 million decreased (15.3)% compared to Q3 2021; Q3 non-GAAP revenue excluding divestitures and on a constant currency basis (1) increased 2.7%, reflecting solid demand in both the Industrial and Healthcare segments, despite supply chain and macroeconomic challenges and lower sales to certain dental market customers Net loss of $(37.4) million, diluted loss per share of $(0.30), and diluted non-GAAP loss per share (1) of $(0.05)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910638/000117184322007258/0001171843-22-007258-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$132.3 million"},{"label":"Net income","value":"$(37.4) million"},{"label":"EPS","value":"$(0.30)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}